Free Word download • Edit online • Save & share with Drive • Export to PDF
A Share Subscription Agreement for Venture Capital is a legally binding contract under which a company issues new shares directly to one or more venture capital investors in exchange for a defined capital investment at an agreed price per share. Unlike a share purchase agreement — which transfers existing shares between parties without changing the company's share capital — a subscription agreement creates fresh equity, increases the company's issued share capital, and channels the investment proceeds directly onto the company's balance sheet. It is the primary closing document for most priced seed, Series A, and later VC financing rounds, governing every material aspect of the transaction: the share class and number, subscription price, conditions that must be satisfied before closing, representations each party makes about their legal standing and the accuracy of disclosed information, and the investor rights that attach to the shares after closing.
Proceeding with a venture capital investment without a properly executed share subscription agreement exposes both the company and the investor to significant legal and financial risk. Without it, the investor has no enforceable claim to specific shares, the share class, or the rights — anti-dilution, information, pre-emption participation — that make the investment commercially viable. The company, for its part, has no contractual mechanism to confirm the investor's accreditation status, enforce representations about their authority to invest, or restrict immediate resale of shares that could destabilize the cap table. Courts will not imply equity issuance terms from a term sheet or email exchange alone, and securities regulators in the US, Canada, and the UK require documented evidence of an applicable exemption from registration at the time of each issuance. A complete, signed subscription agreement creates the paper trail that closes the deal cleanly, satisfies regulatory requirements, protects founders against post-closing warranty disputes, and gives investors the contractual foundation they need to protect their position through subsequent financing rounds.
| If your situation is… | Use this template |
|---|---|
| Early-stage investment with valuation uncertainty and simple terms | SAFE Agreement (Simple Agreement for Future Equity) |
| Short-term convertible debt before a priced round | Convertible Note Agreement |
| Priced seed or Series A round issuing preferred shares to institutional VCs | Share Subscription Agreement Venture Capital |
| Transferring existing shares from a founder or early investor to a new buyer | Share Purchase Agreement |
| Governing ongoing rights and obligations among all shareholders post-close | Shareholders Agreement |
| Issuing shares to employees or advisors under an equity incentive plan | Stock Option Agreement |
| Angel or seed round with multiple small investors on identical terms | Seed Investment Agreement |
Why it matters: If the articles have not been amended to create the share class being issued, the allotment is invalid — the investor has paid but received no valid shares, creating immediate legal and regulatory exposure for both parties.
Fix: Use a closing checklist that requires sign-off confirmation for every condition precedent before any funds move. Do not initiate the wire until all items are checked.
Why it matters: Without a deadline, either party can delay closing indefinitely — the investor can withdraw after market conditions change, or the company can stall allotment. The transaction is commercially stranded.
Fix: Include a long-stop date of 30–60 days from signing. Either party may terminate if conditions are not satisfied by that date, and neither owes damages for a clean termination.
Why it matters: Undisclosed liabilities, existing option grants, IP disputes, or pending regulatory actions discovered post-closing become full warranty claims against the company — potentially equal to the entire investment amount.
Fix: Treat the Disclosure Schedule as a legal document, not an afterthought. Have outside counsel review it alongside the representations before signing.
Why it matters: An investor who immediately sells or transfers shares after closing disrupts the cap table, may trigger securities resale restrictions, and signals to future investors that the lead VC had no conviction in the company.
Fix: Include a minimum 12-month lock-up from closing, with any post-lock-up transfers subject to a right of first refusal in favour of existing shareholders.
Why it matters: A subscription agreement governs the issuance transaction only. Without a shareholders' agreement, ongoing governance rights — board composition, reserved matters, exit mechanics — have no contractual home and default to the articles of association, which are rarely investor-protective.
Fix: Execute a shareholders' agreement at the same closing, or confirm that an existing shareholders' agreement is being amended to include the new investor by deed of adherence.
Why it matters: Vague anti-dilution language — 'the investor will be protected against dilution' — is unenforceable. Courts cannot calculate an adjustment without knowing whether broad-based weighted average, narrow-based, or full ratchet applies.
Fix: Specify the exact formula in a numbered schedule. Broad-based weighted average is the market standard for most VC rounds and the least disruptive to the cap table in a down round.
In plain language: Identifies the company (the issuer) and each subscribing investor by full legal name and jurisdiction, and states the background and commercial purpose of the agreement.
This Share Subscription Agreement is entered into on [DATE] between [COMPANY LEGAL NAME], a [ENTITY TYPE] incorporated under the laws of [JURISDICTION] ('Company'), and [INVESTOR LEGAL NAME] ('Investor'). The Company wishes to issue, and the Investor wishes to subscribe for, [NUMBER] [CLASS] shares on the terms set out herein.
Common mistake: Using a trade name instead of the registered legal entity name for either party. A mismatch with the share register or corporate registry invalidates the allotment and requires a corrective resolution.
In plain language: States the number of shares being subscribed, the class of shares, the subscription price per share, and the total aggregate investment amount the investor will pay.
The Investor agrees to subscribe for [NUMBER] [CLASS] shares at a price of $[PRICE PER SHARE] per share, for an aggregate subscription price of $[TOTAL AMOUNT] ('Subscription Price'), payable on [CLOSING DATE / upon satisfaction of Conditions Precedent].
Common mistake: Omitting the share class (common vs. preferred) and its associated rights. If class is unspecified, the investor may receive shares with no preferential economic or governance rights, making the investment terms unenforceable.
In plain language: Lists every event that must occur before either party is obligated to complete — such as board approval, articles amendment, waiver of pre-emption rights, and satisfactory due diligence.
The obligations of the parties are conditional upon: (a) approval of the subscription by the Company's board of directors; (b) amendment of the Company's articles to create the [CLASS] share class; (c) written waiver of pre-emption rights by all existing shareholders; and (d) the Investor's completion of due diligence to its satisfaction.
Common mistake: Listing conditions precedent without a long-stop date. Without a deadline for satisfaction, either party can delay closing indefinitely, leaving the transaction in limbo.
In plain language: Specifies the bank account, currency, payment method, and timeline for transferring the subscription price, and the steps the company must complete to allot and register the shares at closing.
On the Closing Date, the Investor shall transfer the Subscription Price to the Company's bank account ([ACCOUNT DETAILS]) by wire transfer in immediately available funds. Within [5] business days of receipt, the Company shall allot the Shares, update its share register, and deliver a share certificate to the Investor.
Common mistake: No confirmation mechanism for receipt of funds before shares are allotted. Issuing shares before cleared funds arrive creates a situation where the company has diluted existing shareholders with no cash received.
In plain language: Statements made by the company — confirmed as true at signing and at closing — covering incorporation status, authority to issue shares, absence of material litigation, accuracy of disclosed financials, and no undisclosed liabilities.
The Company represents and warrants to the Investor that: (a) it is duly incorporated and in good standing; (b) it has the power and authority to execute this Agreement and issue the Shares; (c) the Shares will be validly issued, fully paid, and free from encumbrances; and (d) the Disclosure Schedule attached hereto is complete and accurate in all material respects.
Common mistake: Allowing the company to give warranties 'to the best of the directors' knowledge' without a corresponding obligation to conduct reasonable inquiry. This materially weakens the investor's ability to claim for a breach discovered post-closing.
In plain language: Statements made by the investor confirming they are an accredited or sophisticated investor, that they have authority to make the investment, and that they are acquiring the shares for investment and not for immediate resale.
The Investor represents and warrants to the Company that: (a) it is a [qualified / accredited / sophisticated] investor as defined under [APPLICABLE SECURITIES LAW]; (b) it has full legal capacity and authority to enter into this Agreement; and (c) it is acquiring the Shares for investment purposes and not with a view to distribution.
Common mistake: Omitting investor-side representations in deals where both parties are sophisticated. Without them, the company has no contractual basis to rely on an exemption from securities registration requirements.
In plain language: Addresses any existing shareholders' right to subscribe pro rata to new shares, confirms either that those rights have been validly waived or that they do not apply to the current issuance.
Each existing shareholder has, by separate written waiver dated [DATE], irrevocably waived their pre-emption rights in respect of the Shares to be issued pursuant to this Agreement. The Company confirms that no further pre-emption obligations exist in respect of this issuance.
Common mistake: Closing the round without obtaining pre-emption waivers from all shareholders entitled to them. This can render the share allotment voidable and expose the company's board to claims from shareholders whose rights were overlooked.
In plain language: Sets out the ongoing rights the investor receives upon subscription — including information rights (monthly financials, annual accounts), inspection rights, anti-dilution protection, and participation rights in future rounds.
Following Closing, the Investor shall be entitled to: (a) receive unaudited monthly management accounts within [15] business days of each month-end; (b) receive audited annual accounts within [90] days of fiscal year-end; (c) participate pro rata in future equity issuances; and (d) the benefit of [broad-based weighted average] anti-dilution protection on the terms set out in Schedule [X].
Common mistake: Granting information rights without a confidentiality carve-out. Investors receiving financial data are then free to share it unless the agreement expressly restricts onward disclosure.
In plain language: Restricts the investor from selling or transferring the subscribed shares for a defined lock-up period or without first offering them to existing shareholders (right of first refusal) or obtaining board consent.
The Investor shall not transfer, assign, or otherwise dispose of any Shares for a period of [12] months from the Closing Date without the prior written consent of the Board. Thereafter, any proposed transfer is subject to a right of first refusal in favour of existing shareholders on the terms set out in Schedule [Y].
Common mistake: No lock-up period at all for early-stage investors. Without one, a VC fund can flip shares immediately after closing, destabilizing the cap table and undermining founder and employee confidence.
In plain language: Specifies which jurisdiction's law governs the agreement and the forum — litigation or arbitration — for resolving disputes, along with any applicable arbitration rules and seat.
This Agreement is governed by and construed in accordance with the laws of [STATE / PROVINCE / COUNTRY]. Any dispute arising out of or in connection with this Agreement shall be finally resolved by [binding arbitration under [AAA / LCIA / ICC] Rules / the courts of [JURISDICTION]], with proceedings conducted in [CITY / LANGUAGE].
Common mistake: Choosing a governing law that has no connection to where the company is incorporated or where the investor is domiciled. Courts in several jurisdictions will apply local mandatory securities law regardless of the contractual choice, creating unexpected compliance obligations.
Enter the company's exact registered legal name, entity type (e.g., Delaware C-Corp, Ontario Inc., UK Ltd.), and registered address. Do the same for each investor entity — fund name, general partner, and domicile.
💡 Cross-reference the company's certificate of incorporation and the investor's fund formation documents to confirm legal names before execution.
State whether the shares being issued are common, preferred Series A, or a new class. Specify the exact number of shares, price per share, and total aggregate consideration. Confirm these figures reconcile with the pre-money valuation and post-money cap table.
💡 Attach a pro forma cap table as Schedule A to the agreement — it eliminates ambiguity and prevents post-closing disputes about dilution percentages.
List every item that must be completed before closing — board resolutions, articles amendments, pre-emption waivers, due diligence sign-off, and any regulatory approvals. Assign responsibility for each and set a long-stop date for satisfaction.
💡 A 30–60 day long-stop date is standard for most seed and Series A rounds. Build in buffer for articles amendment filings, which can take 5–10 business days at company registries.
Work through each company representation and populate the Disclosure Schedule with any known exceptions — pending litigation, IP ownership issues, existing options, outstanding debts, or material contracts that could affect the investment thesis.
💡 An accurate Disclosure Schedule is the company's primary defence against a warranty claim post-closing. Incomplete disclosure is far more damaging than disclosing a known issue upfront.
Identify the correct accreditation or sophistication standard for the investor under the governing jurisdiction's securities law — Rule 506(b) or 506(c) in the US, Section 2.3 of NI 45-106 in Canada, or the professional investor regime under MiFID II in the EU.
💡 Retain signed investor questionnaires confirming accreditation before closing — they are your primary evidence of securities law exemption compliance.
Insert the company's designated bank account details for the wire transfer, specify the currency and value date, and set out the precise sequence of closing steps — funds received, board resolution passed, shares allotted, share register updated, share certificate issued.
💡 Use a closing checklist as an exhibit to the agreement so both parties can track completion of each step in real time on closing day.
Define the exact scope of information rights (monthly vs. quarterly, audited vs. unaudited), anti-dilution mechanics (broad-based weighted average is most investor-friendly without being punitive to founders), and participation rights in future rounds.
💡 Limit information rights to investors holding above a threshold percentage (e.g., 5%) to avoid reporting obligations to every small investor in a syndicated round.
Both the company (by an authorized director or officer) and each investor must sign the agreement — and all conditions precedent must be satisfied — before any subscription price is wired. Keep fully executed originals (wet-ink or e-signed with timestamped audit trail) for each party.
💡 Use a reputable e-signature platform to timestamp execution. In most jurisdictions, e-signatures are as enforceable as wet-ink signatures for commercial contracts of this type.
Standard company warranties in a VC subscription agreement cover: due incorporation and good standing, authority to issue the shares, valid and fully paid share allotment, accuracy of disclosed financial statements, absence of undisclosed material liabilities, no pending material litigation, clean ownership of key intellectual property, and compliance with applicable laws. Each warranty is qualified by a Disclosure Schedule that carves out known exceptions — making the schedule one of the most legally significant documents in the deal.
The market standard for most Series A and seed rounds is broad-based weighted average anti-dilution protection. This adjusts the investor's effective price per share downward — on a weighted formula — if the company later issues shares at a lower price. Full ratchet protection, which resets the investor's price to match the lower round entirely, is considered punitive and is rarely accepted by founders or their counsel outside distressed situations. The specific formula should always be set out in a numbered schedule to the agreement.
Yes — the core structure of a share subscription agreement is the same whether the investor is an institutional VC fund or an individual angel. The main differences in angel deals are typically simpler representations and warranties, lighter investor rights (quarterly rather than monthly reporting, for example), and smaller or absent anti-dilution provisions. For very early rounds with valuation uncertainty, a SAFE or convertible note is often preferred over a priced subscription agreement entirely.
A convertible note is debt that converts into equity at a future priced round, avoiding the need to agree a valuation today. A share subscription agreement issues equity immediately at an agreed price. Convertible notes suit very early stages where valuation is contested; subscription agreements are the right instrument once a valuation has been negotiated and a round is being closed.
A share purchase agreement transfers existing shares from a selling shareholder to a buyer — no new shares are created and no capital enters the company. A share subscription agreement creates new shares and channels investment capital directly into the company. VC financing rounds almost always use subscription agreements because the purpose is to fund the company, not to buy out an existing holder.
A shareholders' agreement governs the ongoing relationship among all shareholders — board rights, exit mechanics, drag-along, tag-along, and reserved matters. A share subscription agreement covers only the issuance transaction. The two documents work together: the subscription agreement closes the deal; the shareholders' agreement governs what comes after. Executing one without the other leaves significant gaps.
A SAFE is a non-debt instrument that gives an investor the right to receive equity at a future priced round, typically with a valuation cap or discount. It defers all share issuance and pricing until that round. A share subscription agreement is the right tool when parties have agreed a valuation and want to issue priced shares now. SAFEs are simpler and faster for pre-seed stages; subscription agreements are more appropriate from seed onwards.
IP ownership representations cover source code and data; investor rights include access to ARR and churn metrics; anti-dilution is critical given frequent subsequent financing rounds.
Conditions precedent may include satisfactory IP due diligence on patent filings and licensing agreements; milestone-linked tranches replace single-close subscriptions in many deals.
Regulatory approvals — payment institution licences, money transmitter registrations — are commonly added as conditions precedent; investor representations must confirm no regulatory disqualification.
Brand IP and domain ownership are key warranty items; high-growth revenue projections require specific financial representation carve-outs; multiple smaller investors in a syndicate increases the complexity of pre-emption waiver collection.
Government grant and subsidy agreements are warranted as valid and not in default; project asset ownership and regulatory permits are typically scheduled as disclosure items.
Key-person provisions are often added to investor rights — giving the investor termination or conversion rights if a named founder departs; client concentration is a standard warranty disclosure item.
US VC subscription agreements are typically governed by Delaware law given Delaware's well-developed corporate case law. The investor's accreditation must be confirmed under Regulation D (Rule 506(b) or 506(c)) to exempt the issuance from SEC registration. California Blue Sky laws and other state securities regulations may impose additional filing or notice requirements within 15 days of the first sale. Non-compete provisions for founders are generally unenforceable in California, which affects related agreements in the round.
Canadian share subscription agreements must comply with applicable provincial securities legislation — most commonly the accredited investor exemption under National Instrument 45-106. Quebec-based investors or companies require agreements in French or bilingual form for provincially regulated entities. The CBCA and provincial Business Corporations Acts govern share allotment mechanics and the timeline for updating share registers. Canadian counsel should review anti-dilution and voting provisions to ensure consistency with the applicable corporate statute.
UK subscription agreements must comply with the Financial Services and Markets Act 2000 — a financial promotion exemption (e.g., sophisticated investor or high-net-worth individual) must be confirmed in writing before the agreement is circulated. Share allotment requires a board resolution under the Companies Act 2006, and the return of allotments (SH01) must be filed at Companies House within one month of allotment. The Enterprise Investment Scheme (EIS) and Seed EIS (SEIS) provide significant tax relief to qualifying UK investors, and the subscription agreement must confirm EIS eligibility conditions are not breached.
EU member state requirements vary significantly — French, German, and Dutch corporate law each impose different share allotment formalities, some requiring notarial execution. The EU Prospectus Regulation exempts most private VC placements below €8M from full prospectus requirements, but national private placement regimes and investor qualification rules differ by country. GDPR implications arise where investor due diligence involves processing personal data of company employees or customers. Cross-border rounds spanning multiple EU jurisdictions typically require counsel in each relevant member state.
| Path | Best for | Cost | Time |
|---|---|---|---|
| Use the template | Seed rounds under $500K with a single investor, straightforward share class, and no complex IP or regulatory issues | Free | 2–4 hours to complete and review |
| Template + legal review | Seed or Series A rounds between $500K and $5M, multiple investors, preferred share class with anti-dilution, or cross-border parties | $1,500–$5,000 for outside counsel review and negotiation support | 3–10 business days |
| Custom drafted | Series A and later rounds above $5M, institutional VC lead investors, complex capital structures, multi-jurisdiction companies, or heavily regulated industries | $10,000–$50,000+ in legal fees across company and investor counsel | 2–6 weeks |
This document is one of 3,000+ business & legal templates included in Business in a Box.
Access over 3,000+ business and legal templates for any business task, project or initiative.
Customize your ready-made business document template and save it in the cloud.
Share your files and folders with your team. Create a space of seamless collaboration.
"Fantastic value! I'm not sure how I'd do without it. It's worth its weight in gold and paid back for itself many times."
"I have been using Business in a Box for years. It has been the most useful source of templates I have encountered. I recommend it to anyone."
"It has been a life saver so many times I have lost count. Business in a Box has saved me so much time and as you know, time is money."
Stop downloading documents. Start operating with clarity. Business in a Box gives you the Business Operating System used by over 250,000 companies worldwide to structure, run, and grow their business.
Start free · No credit card required
